Cargando…

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Ismail, Tevfik F, Jabbour, Andrew, Gulati, Ankur, Mallorie, Amy, Raza, Sadaf, Cowling, Thomas E, Das, Bibek, Khwaja, Jahanzaib, Wage, Rick, Moon, James, Varnava, Amanda, Shakespeare, Carl, Elliott, Perry, OHanlon, Rory, Pennell, Dudley J, Prasad, Sanjay K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559668/ http://dx.doi.org/10.1186/1532-429X-15-S1-O67

Ejemplares similares

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study
por: Ismail, Tevfik F, et al.
Publicado: (2014)

Role of T1 and T2-mapping in assessing the myocardial interstitium in hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
por: Ismail, Tevfik F, et al.
Publicado: (2013)

The relationship between interstitial fibrosis and contractile function in HCM: a combined T1-mapping and CSPAMM tagging study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
por: Halliday, Brian P., et al.
Publicado: (2017)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Potential of pre-contrast T1 mapping as a marker of interstitial fibrosis in severe aortic stenosis
por: Jabbour, Andrew, et al.
Publicado: (2012)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Bolus administration T1 mapping as a marker of interstitial myocardial fibrosis in severe aortic stenosis
por: Wage, Rick, et al.
Publicado: (2012)

Genotype positive hypertrophic cardiomyopathy is associated with myocardial perfusion abnormalities
por: Keenan, Niall G, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Cardiovascular magnetic resonance T2 mapping detects myocardial edema in patients with chronic dilated cardiomyopathy
por: He, Taigang, et al.
Publicado: (2012)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2009)

Effects of anabolic steroid use on myocardial perfusion in body-builders: a quantitative cardiovascular magnetic resonance Study
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Comprehensive Phenotypic Characterization of Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Coronary Artery Disease
por: Jones, Richard E., et al.
Publicado: (2023)

Diagnostic accuracy of half-contrast dose bSSFP vs full-contrast dose hEPI MR perfusion imaging in patients with known or suspected coronary artery disease
por: Bucciarelli-Ducci, Chiara, et al.
Publicado: (2009)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2013)

Non-invasive assessment of interstitial myocardial fibrosis in pressure-overload left ventricular hypertrophy
por: Jabbour, Andrew, et al.
Publicado: (2012)

The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death
por: Freitas, Pedro, et al.
Publicado: (2019)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

Acquiring multiple slices in a single breath-hold. Is it practical for routine workflow?
por: Wage, Ricardo, et al.
Publicado: (2009)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Doesch, Christina, et al.
Publicado: (2017)

Rapid assessment of myocardial scar and viability in ischemic heart disease: a cardiovascular magnetic resonance study
por: Locca, Didier, et al.
Publicado: (2009)

Bilateral adrenal hemorrhage in the background of Escherichia coli sepsis: a case report
por: Khwaja, Jahanzaib
Publicado: (2017)

Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
por: Khan, Tina, et al.
Publicado: (2015)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance
por: Kirk, Paul, et al.
Publicado: (2011)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Quantitative assessment of myocardial extracellular volume fraction in non-ischemic dilated cardiomyopathy and its relation to systolic dysfunction
por: Ali, Aamir, et al.
Publicado: (2013)

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
por: Rodriguez-Granillo, Gaston A., et al.
Publicado: (2016)

Impact of fibrosis and sympathetic activity on coronary flow reserve in hypertrophiccardiomyopathy
por: Gaemperli, Oliver, et al.
Publicado: (2011)

Myocardial T1 and ECV mapping: how we optimise technical aspects of acquisition
por: Wage, Ricardo, et al.
Publicado: (2016)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
por: Smith, Brandon M, et al.
Publicado: (2013)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v0tvcsavmqesqbijtdrka674s3